← Alle mensen

AN

Adnan Nagrial

2 publicaties

PubMed → Google Scholar →

Publicaties op Oncologisch.com

Subcutaneous versus intravenous amivantamab, both in combination with lazertinib, in refractory EGFR-mutated non-smal...
European journal of cancer (Oxford, England : 1990) · 9 september 2025
Oleclumab plus durvalumab plus chemo bij pancreascarcinoom: fase Ib/II
Clinical cancer research : an official journal of the American Association for Cancer Research · 15 oktober 2024